Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis

Thompson, RJ; Artan, R; Baumann, U; Calvo, PL; Czubkowski, P; Dalgic, B; D'Antiga, L; Di Giorgio, A; Durmaz, Ö; Gonzalès, E; Grammatikopoulos, T; Gupte, G; Hardikar, W; Houwen, RHJ; Kamath, BM; Karpen, SJ; Lacaille, F; Lachaux, A; Lainka, E; Loomes, KM; Mack, CL; Mattsson, JP; Mckiernan, P; Ni, QH; Özen, H; Rajwal, SR; Roquelaure, B; Shteyer, E; Sokal, E; Sokol, RJ; Soufi, N; Sturm, E; Tessier, ME; van der Woerd, WL; Verkade, HJ; Vittorio, JM; Wallefors, T; Warholic, N; Yu, QF; Horn, P; Kjems, L

Thompson, RJ (通讯作者)，Kings Coll Hosp London, Inst Liver Studies, Denmark Hill, London SE5 9RS, England.

JHEP REPORTS, 2023; 5 (8):

Abstract

Background & Aims: PEDFIC 2, an ongoing, open-label, 72-week study, evaluates odevixibat, an ileal bile acid transporter inhibitor, in patients wi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索